Search Orphan Drug Designations and Approvals
-
| Generic Name: | Alitretinoin |
|---|---|
| Trade Name: | Panretin |
| Date Designated: | 04/10/1992 |
| Orphan Designation: | Treatment of acute promyelocytic leukemia |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Marketing Approval Date: | N/A |
| Approved Labeled Indication: | |
| Exclusivity End Date: | N/A |
| Exclusivity Protected Indication*: | |
| Sponsor: |
Ligand Pharmaceuticals, Inc. 10275 Science Center Dr. San Diego, California 92121 USA The sponsor address listed is the last reported by the sponsor to OOPD. |
-
